You are here:

Serono Ltd

Name SMC ID No Status Sub. Type
 
cetuximab (Erbitux) 155/05 Superseded IRP
cetuximab (Erbitux) 155/05 Superseded Full submission
cetuximab (Erbitux) 547/09 Not Recommended Non submission
cetuximab (Erbitux) 543/09 Superseded Full submission
cetuximab (Erbitux) 543/09 Superseded Resubmission
cetuximab (Erbitux) 1012/14 Superseded Full submission
choriogonadotropin alfa (Ovitrelle) 263/06 Not Recommended Non submission
choriogonadotropin alfa (Ovitrelle) 264/06 Not Recommended Non submission
choriogonadotropin alfa 250 mcg/0.5 ml pre filled syringe (Ovitrelle) 263/06 Accepted Abbreviated Submission
choriogonadotropin alfa 250 mcg/0.5 ml pre-filled syringe (Ovitrelle) 264/06 Accepted Abbreviated Submission
Efalizumab (Raptiva®) 146/04 Marketing Authorisation Withdrawn Full submission
Estradiol & levonorgesteral patches (FemSeven Sequi®) 20/02 Accepted Full submission
Estradiol & levonorgestrel patches (FemSeven Conti®) 28/02 Accepted Full submission
follitropin alpha/lutropin alpha (Pergoveris) 444/08 Accepted Abbreviated Submission
interferon beta-1a (Rebif) 825/12 Not Recommended Non submission
metformin (Glucophage SR) 148/04 Restricted Resubmission
Metformin hydrochloride (Glucophage SR®) 148/04 Not Recommended Resubmission
Metformin hydrochloride (Glucophage SR®) 148/04 Not Recommended Full submission
metformin hydrochloride (Glucophage) 1308/18 Not Recommended Non submission
metformin hydrochloride (Glucophage) 500mg/1000mg Powder for Solution 610/10 Abbreviated Submission
Nicotinic acid modified release tablet (Niaspan®) 93/04 Not Recommended Resubmission
Nicotinic acid modified release tablets (Niaspan®) 93/04 Not Recommended Full submission
Nicotonic acid modified release tabs (Niaspan®) 93/04 Not Recommended Resubmission
sapropterin (Kuvan) 558/09 Not Recommended Non submission
somatropin (Saizen) 737/11 Accepted Abbreviated Submission

Back